The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Fibroblast Growth Factor 21 Regulates Lipolysis in White Adipose Tissue But Is Not Required for Ketogenesis and Triglyceride Clearance in Liver
Abstract
Fibroblast growth factors (Fgfs) are polypeptide growth factors with diverse functions. Fgf21, a unique member of the Fgf family, is expected to function as a metabolic regulator in an endocrine manner. Hepatic Fgf21 expression was increased by fasting. The phenotypes of hepatic Fgf21 transgenic or knockdown mice and high-fat, low-carbohydrate ketogenic diet-fed mice suggests that Fgf21 stimulates lipolysis in the white adipose tissue during normal feeding and is required for ketogenesis and triglyceride clearance in the liver during fasting. However, the physiological roles of Fgf21 remain unclear. To elucidate the physiological roles of Fgf21, we generated Fgf21 knockout (KO) mice by targeted disruption. Fgf21 KO mice were viable, fertile, and seemingly normal. Food intake, oxygen consumption, and energy expenditure were also essentially unchanged in Fgf21 KO mice. However, hypertrophy of adipocytes, decreased lipolysis in adipocytes, and decreased blood nonesterified fatty acid levels were observed when Fgf21 KO mice were fed normally. In contrast, increased lipolysis in adipocytes and increased blood nonesterified fatty acid levels were observed in Fgf21 KO mice by fasting for 24 h, indicating that Fgf21 stimulates lipolysis in the white adipose tissue during feeding but inhibits it during fasting. In contrast, unexpectedly, hepatic triglyceride levels were essentially unchanged in Fgf21 KO mice. In addition, ketogenesis in Fgf21 KO mice was not impaired by fasting for 24 h. The present results indicate that Fgf21 regulates lipolysis in adipocytes in response to the metabolic state but is not required for ketogenesis and triglyceride clearance in the liver.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Under fasted conditions, FGF21 increases hepatic gluconeogenesis, β-oxidation, and ketogenesis in mice [142,154].”
From Hepatokines and metabolism: Deciphering communication from the liver (2021) · cites this paper as [142]
Citations
Cites
FGF-21 as a novel metabolic regulator
Kharitonenkov, A., Shiyanova, T. L., Koester, A., Ford, A. M., Micanovic, R., Galbreath, E. J., Sandusky, G. E., Hammond, L. J., Moyers, J. S., Owens, R. A., et al. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23606 · Cited by 2,125
Peroxisome proliferator–activated receptor α mediates the adaptive response to fasting
Kersten, S., Seydoux, J., Peters, J. M., Gonzalez, F. J., Desvergne, B., & Wahli, W. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6223 · Cited by 1,649
Inagaki, T., Dutchak, P., Zhao, G., Ding, X., Gautron, L., Parameswara, V., Li, Y., Goetz, R., Mohammadi, M., Esser, V., et al. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.05.003 · Cited by 1,504
Badman, M. K., Pissios, P., Kennedy, A. R., Koukos, G., Flier, J. S., & Maratos-Flier, E. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.05.002 · Cited by 1,495
Cahill, G. F. (2006) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.26.061505.111258 · Cited by 1,360
Evolution of the Fgf and Fgfr gene families.
Itoh, N., & Ornitz, D. (2004) · Trends in Genetics · doi:10.1016/j.tig.2004.08.007 · Cited by 1,123
Fibroblast Growth Factor 21 Corrects Obesity in Mice
Coskun, T., Bina, H. A., Schneider, M. A., Dunbar, J. D., Hu, C. C., Chen, Y., Moller, D. E., & Kharitonenkov, A. (2008) · Endocrinology · doi:10.1210/en.2008-0816 · Cited by 1,031
Leone, T. C., Weinheimer, C. J., & Kelly, D. P. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.13.7473 · Cited by 943
Identification of a novel FGF, FGF-21, preferentially expressed in the liver
Nishimura, T., Nakatake, Y., Konishi, M., & Itoh, N. (2000) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(00)00067-1 · Cited by 847
Functions and regulations of fibroblast growth factor signaling during embryonic development
Thisse, B., & Thisse, C. (2005) · Developmental Biology · doi:10.1016/j.ydbio.2005.09.011 · Cited by 508
Cited by
Sorted by citations
Items 101–200 of 353
Circulating FGF21 Levels in Human Health and Metabolic Disease
Keuper, M., Häring, H., & Staiger, H. (2019) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-0879-2968 · Cited by 83
Guo, R., Xu, X., Babcock, S. A., Zhang, Y., & Ren, J. T. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.10.009 · Cited by 80
RetractedSo, W. Y., Cheng, Q., Xu, A., Lam, K. S. L., & Leung, P. S. (2015) · Cell Death and Disease · doi:10.1038/cddis.2015.80 · Cited by 79
Muscle mitochondrial stress adaptation operates independently of endogenous FGF21 action
Ost, M., Coleman, V., Voigt, A., van Schothorst, E. M., Keipert, S., van der Stelt, I., Ringel, S., Graja, A., Ambrosi, T., Kipp, A. P., et al. (2016) · Molecular Metabolism · doi:10.1016/j.molmet.2015.11.002 · Cited by 75
Asrih, M., Altirriba, J., Rohner‐Jeanrenaud, F., & Jornayvaz, F. R. (2015) · PLoS ONE · doi:10.1371/journal.pone.0126364 · Cited by 75
Stressed Liver and Muscle Call on Adipocytes with FGF21
Luo, Y., & McKeehan, W. L. (2013) · Frontiers in Endocrinology · doi:10.3389/fendo.2013.00194 · Cited by 75
Fibroblast growth factor 21 is not required for the antidiabetic actions of the thiazoladinediones
Adams, A. C., Coşkun, T., Cheng, C., O’Farrell, L. S., DuBois, S. L., & Kharitonenkov, A. (2013) · Molecular Metabolism · doi:10.1016/j.molmet.2013.05.005 · Cited by 75
Cardioprotective proteins upregulated in the liver in response to experimental myocardial ischemia
Liu, S. Q., Tefft, B. J., Roberts, D., Zhang, L., Ren, Y., Li, Y. C., Huang, Y., Zhang, D., Phillips, H. R., & Wu, Y. H. (2012) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00362.2012 · Cited by 78
Fibroblast growth factor 21, the endocrine FGF pathway and novel treatments for metabolic syndrome
Zhang, J., & Li, Y. (2013) · Drug Discovery Today · doi:10.1016/j.drudis.2013.10.021 · Cited by 73
Molecular mechanisms underlying metabolic syndrome: the expanding role of the adipocyte
Armani, A., Berry, A., Cirulli, F., & Caprio, M. (2017) · The FASEB Journal · doi:10.1096/fj.201601125rrr · Cited by 76
Effects of fibroblast growth factor 21 on the heart
Tanajak, P., Chattipakorn, S. C., & Chattipakorn, N. (2015) · Journal of Endocrinology · doi:10.1530/joe-15-0289 · Cited by 72
Human FGF-21 Is a Substrate of Fibroblast Activation Protein
Coppage, A. L., Heard, K. R., DiMare, M. T., Liu, Y., Wu, W., Lai, J. H.-S., & Bachovchin, W. W. (2016) · PLoS ONE · doi:10.1371/journal.pone.0151269 · Cited by 71
CREBH-FGF21 axis improves hepatic steatosis by suppressing adipose tissue lipolysis
Park, J., Xu, X., Cho, S., Hur, K. Y., Lee, M., Kersten, S., & Lee, A. (2016) · Scientific Reports · doi:10.1038/srep27938 · Cited by 71
Fasting-induced hormonal regulation of lysosomal function
Chen, L., Wang, K., Long, A., Jia, L., Zhang, Y., Deng, H., Li, Y., Han, J., & Wang, Y. (2017) · Cell Research · doi:10.1038/cr.2017.45 · Cited by 71
Spann, R. A., Morrison, C. D., & den Hartigh, L. J. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.802541 · Cited by 76
Goto, T., Hirata, M., Aoki, Y., Iwase, M., Takahashi, H., Kim, M., Li, Y., Jheng, H., Nomura, W., Takahashi, N., et al. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.767590 · Cited by 72
Hepatic Glucagon Receptor Signaling Enhances Insulin-Stimulated Glucose Disposal in Rodents
Kim, T., Holleman, C. L., Nason, S. R., Arble, D. M., Ottaway, N., Chabenne, J. R., Loyd, C., Kim, J., Sandoval, D. A., Drucker, D. J., et al. (2018) · Diabetes · doi:10.2337/db18-0068 · Cited by 69
Maida, A., Chan, J. S. K., Sjøberg, K. A., Zota, A., Schmoll, D., Kiens, B., Herzig, S., & Rose, A. J. (2017) · Molecular Metabolism · doi:10.1016/j.molmet.2017.06.009 · Cited by 68
Yano, K., Yamaguchi, K., Seko, Y., Okishio, S., Ishiba, H., Tochiki, N., Takahashi, A., Kataoka, S., Okuda, K., Liu, Y. X., et al. (2021) · Laboratory Investigation · doi:10.1038/s41374-021-00680-9 · Cited by 63
Tyynismaa, H., Raivio, T., Hakkarainen, A., Ortega‐Alonso, A., Lundbom, N. M. I., Kaprio, J. A., Rissanen, A., Suomalainen, A., & Pietiläinen, K. H. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-1326 · Cited by 61
Struik, D., Dommerholt, M. B., & Jonker, J. W. (2019) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000599 · Cited by 61
Jois, T., Chen, W., HOWARD, V. G., Harvey, R. E., Youngs, K., Thalmann, C., Saha, P., Chan, L., Cowley, M. A., & Sleeman, M. W. (2017) · Molecular Metabolism · doi:10.1016/j.molmet.2017.07.006 · Cited by 66
Pashkov, V., Huang, J., Parameswara, V., Kędzierski, W., Kurrasch, D. M., Tall, G. G., Esser, V., Gerard, R. D., Uyeda, K., Towle, H. C., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.216234 · Cited by 59
CREB3L3 controls fatty acid oxidation and ketogenesis in synergy with PPARα
Nakagawa, Y., Satoh, A., Tezuka, H., Han, S., Takei, K., IWASAKI, H. O., Yatoh, S., Yahagi, N., Suzuki, H., Iwasaki, Y., et al. (2016) · Scientific Reports · doi:10.1038/srep39182 · Cited by 60
Wang, X., Song, S., Xiao, H., Gao, P., Li, X.-J., & Si, L. (2014) · Cellular Physiology and Biochemistry · doi:10.1159/000363031 · Cited by 58
Physiological modulation of circulating FGF21: relevance of free fatty acids and insulin
Mai, K., Bobbert, T., Groth, C., Aßmann, A., Meinus, S., Kraatz, J., Andres, J., Arafat, A. M., Pfeiffer, A. F. H., Möhlig, M., et al. (2010) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00020.2010 · Cited by 58
Somm, E., Henry, H., Bruce, S. J., Aeby, S., Rosikiewicz, M., Sykiotis, G. P., Asrih, M., Jornayvaz, F. R., Denechaud, P., Albrecht, U., et al. (2017) · JCI Insight · doi:10.1172/jci.insight.91809 · Cited by 58
Maekawa, R., Seino, Y., Ogata, H., Murase, M., Iida, A., Hosokawa, K., Joo, E., Harada, N., Tsunekawa, S., Hamada, Y., et al. (2017) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2017.07.010 · Cited by 56
The impact of keto-adaptation on exercise performance and the role of metabolic-regulating cytokines
Sherrier, M. C., & Li, H. (2019) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqz145 · Cited by 56
Myokines: Metabolic regulation in obesity and type 2 diabetes
Chen, Z.-T., Weng, Z.-X., Lin, J. D., & Meng, Z.-X. (2024) · Life Metabolism · doi:10.1093/lifemeta/loae006 · Cited by 58
Hormone-like fibroblast growth factors and metabolic regulation
Long, Y. C., & Kharitonenkov, A. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.04.002 · Cited by 55
Wu, F., Wang, B., Zhang, S., Shi, L., Wang, Y., Xiong, R., Pan, X., Gong, F., Li, X., & Lin, Z. (2017) · Clinical Science · doi:10.1042/cs20170271 · Cited by 54
Rush to the fire: FGF21 extinguishes metabolic stress, metaflammation and tissue damage
Luo, Y., Ye, S., Chen, X., Gong, F., Lu, W., & Li, X. (2017) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2017.08.001 · Cited by 56
Xie, T., So, W. Y., Li, X. Y., & Leung, P. S. (2019) · Clinical Science · doi:10.1042/cs20190093 · Cited by 55
Fgf21 Impairs Adipocyte Insulin Sensitivity in Mice Fed a Low-Carbohydrate, High-Fat Ketogenic Diet
Murata, Y., Nishio, K., Mochiyama, T., Konishi, M., Shimada, M., Ohta, H., & Itoh, N. (2013) · PLoS ONE · doi:10.1371/journal.pone.0069330 · Cited by 54
Self-citationZhang, J., Gupte, J., Gong, Y., Weiszmann, J., Zhang, Y., Lee, K. J., Richards, W. G., & Li, Y. (2017) · EBioMedicine · doi:10.1016/j.ebiom.2016.12.016 · Cited by 54
Li, K., Li, L., Yang, M., Liu, H., Boden, G. H., & Yang, G. (2011) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.07.026 · Cited by 55
Fougerat, A., Bruse, J., Polizzi, A., Montagner, A., Guillou, H., & Wahli, W. (2024) · Progress in Lipid Research · doi:10.1016/j.plipres.2024.101303 · Cited by 56
Domingo, P., Gallego-Escuredo, J. M., Domingo, J. C., Gutiérrez, M. D. M., Mateo, G. M., Fernández, I., Vidal, F., Giralt, M., & Villarroya, F. (2010) · AIDS · doi:10.1097/qad.0b013e3283400088 · Cited by 53
Ozaki, Y., Saito, K., Nakazawa, K., Konishi, M., Itoh, N., Hakuno, F., Takahashi, S.-I., Kato, H., & Takenaka, A. (2015) · British Journal Of Nutrition · doi:10.1017/s0007114515002846 · Cited by 51
Fibroblast growth factor 21: a novel biomarker for human muscle-manifesting mitochondrial disorders
Suomalainen, A. (2013) · Expert Opinion on Medical Diagnostics · doi:10.1517/17530059.2013.812070 · Cited by 52
Fibroblast Growth Factor 21 Suppresses Adipogenesis in Pig Intramuscular Fat Cells
Wang, Y., Liu, X., Hou, L., Wu, W., Zhao, S., & Xiong, Y. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms17010011 · Cited by 52
Hashidume, T., Kato, A., Tanaka, T., Miyoshi, S., Itoh, N., Nakata, R., Inoue, H., Oikawa, A., Nakai, Y., Shimizu, M., et al. (2016) · Scientific Reports · doi:10.1038/srep28183 · Cited by 52
Li, Q., Zhang, Y., Ding, D., Yang, Y., Chen, Q., Su, D., Chen, X., Yang, W., Qiu, J., & Ling, W. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-2308 · Cited by 52
Independent links between plasma xanthine oxidoreductase activity and levels of adipokines
Furuhashi, M., Matsumoto, M., Murase, T., Nakamura, T., Higashiura, Y., Koyama, M., Tanaka, M., Moniwa, N., Ohnishi, H., Saitoh, S., et al. (2018) · Journal of Diabetes Investigation · doi:10.1111/jdi.12982 · Cited by 49
Wang, J., Zhu, Q., Cheng, X., Sha, C.-X., & Cui, Y. (2020) · Postgraduate Medicine · doi:10.1080/00325481.2020.1764235 · Cited by 50
Ahmad, Y., Seo, D. S., & Jang, Y. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25137076 · Cited by 49
Fibroblast Growth Factor 21 Mediates Glycemic Regulation by Hepatic JNK
Vernia, S., Cavanagh, J., Barrett, T., Tournier, C., & Davis, R. J. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.02.026 · Cited by 48
Effects of fibroblast growth factor 21 on cell damage in vitro and atherosclerosis in vivo
Zhu, W., Wang, C., Liu, L., Li, Y., Li, X., Cai, J., & Wang, H. (2014) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2014-0227 · Cited by 48
Ojha, A., Ojha, U., Mohammed, R., Chandrashekar, A., & Ojha, H. (2019) · Clinical Pharmacology Advances and Applications · doi:10.2147/cpaa.s202614 · Cited by 52
Yang, C., Wang, C., Ye, M., Jin, C., He, W., Wang, F., McKeehan, W. L., & Luo, Y. (2012) · Nutrition & Metabolism · doi:10.1186/1743-7075-9-94 · Cited by 48
Loyd, C., Magrisso, I. J., Haas, M., Balusu, S., Krishna, R., Itoh, N., Sandoval, D. A., Pérez–Tilve, D., Obici, S., & Habegger, K. M. (2016) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00456.2016 · Cited by 49
Wang, N., Li, J., Li, S., Guo, X., Wu, T., Wang, W., & Li, D. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.09.143 · Cited by 46
Oh, T. J., Sul, W. J., Oh, H. N., Lee, Y.-K., Lim, H. L., Choi, S. H., Park, K. S., & Jang, H. C. (2019) · Scientific Reports · doi:10.1038/s41598-019-56684-5 · Cited by 48
Stemmer, K., Zani, F., Habegger, K. M., Neff, C., Kotzbeck, P., Bauer, M., Yalamanchilli, S., Azad, A., Lehti, M., Martins, P. J. F., et al. (2015) · Diabetologia · doi:10.1007/s00125-015-3668-7 · Cited by 44
Toward reconciling the roles of FGF21 in protein appetite, sweet preference, and energy expenditure
Solon‐Biet, S. M., Clark, X., Bell-Anderson, K. S., Rusu, P. M., Perks, R., Freire, T., Pulpitel, T., Senior, A. M., Hoy, A. J., Aung, O., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.113536 · Cited by 43
Hepatic insulin resistance and increased hepatic glucose production in mice lacking Fgf21
Camporez, J. P., Asrih, M., Zhang, D., Kahn, M., Samuel, V. T., Jurczak, M. J., & Jornayvaz, F. R. (2015) · Journal of Endocrinology · doi:10.1530/joe-15-0136 · Cited by 44
The physiology of MASLD: molecular pathways between liver and adipose tissues
Lee, W., Kipp, Z. A., Bates, E. A., Pauss, S. N., Martinez, G. J., & Hinds, T. D. (2025) · Clinical Science · doi:10.1042/cs20257571 · Cited by 52
β-Klotho promotes glycolysis and glucose-stimulated insulin secretion via GP130
Geng, L., Liao, B., Jin, L., Yu, J., Zhao, X., Zhao, Y., Zhong, L., Wang, B., Li, J., Liu, J., et al. (2022) · Nature Metabolism · doi:10.1038/s42255-022-00572-2 · Cited by 41
Oishi, K., Konishi, M., Murata, Y., & Itoh, N. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.07.125 · Cited by 40
Stress Signaling Between Organs in Metazoa
Owusu-Ansah, E., & Perrimon, N. (2015) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-100814-125523 · Cited by 39
Ryan, K. K., Packard, A. E. B., Larson, K. R., Stout, J., Fourman, S. M., Thompson, A. M. K., Ludwick, K., Habegger, K. M., Stemmer, K., Itoh, N., et al. (2017) · Endocrinology · doi:10.1210/en.2017-00486 · Cited by 42
Can we predict a favourable response to Ketogenic Diet Therapies for drug-resistant epilepsy?
Schoeler, N. E., Cross, J. H., Sander, J. W. A. S., & Sisodiya, S. M. (2013) · Epilepsy Research · doi:10.1016/j.eplepsyres.2013.06.002 · Cited by 39
Wang, N., Zhao, T., Li, S., Sun, X., Li, Z., Li, Y., Li, D., & Wang, W. (2019) · Obesity · doi:10.1002/oby.22376 · Cited by 38
Chalvon-Demersay, T., Even, P. C., Tomé, D., Chaumontet, C., Piedcoq, J., Gaudichon, C., & Azzout-Marniche, D. (2016) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2016.07.002 · Cited by 37
Protein metabolism and related body function: mechanistic approaches and health consequences
Tomé, D., Benoit, S., & Azzout‐Marniche, D. (2020) · Proceedings of The Nutrition Society · doi:10.1017/s0029665120007880 · Cited by 39
Abrosimov, R., Baeken, M. W., Hauf, S., Wittig, I., Hajieva, P., Perrone, C. E., & Moosmann, B. (2024) · GeroScience · doi:10.1007/s11357-023-01059-y · Cited by 37
Luo, Y., Yang, C., Ye, M., Jin, C., Abbruzzese, J. L., Lee, M., Yeung, S. J., & McKeehan, W. L. (2013) · Cancer & Metabolism · doi:10.1186/2049-3002-1-21 · Cited by 36
Cardioprotective mechanisms activated in response to myocardial ischemia.
Liu, S. Q., Tefft, B. J., Zhang, D., Roberts, D., Schuster, D. J., & Wu, A. (2011) · PubMed · Cited by 36
Regulation of fibroblast growth factor 15/19 and 21 on metabolism: in the fed or fasted state
Guan, D., Zhao, L., Chen, D., Yu, B., & Yu, J. (2016) · Journal of Translational Medicine · doi:10.1186/s12967-016-0821-0 · Cited by 36
Emerging Structure–Function Paradigm of Endocrine FGFs in Metabolic Diseases
Luo, Y., Ye, S., Li, X., & Lu, W. (2019) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2018.12.002 · Cited by 37
The Autophagy Inducer Spermidine Protects Against Metabolic Dysfunction During Overnutrition
Liao, C., Kummert, O. M. P., Bair, A. M., Alavi, N., Alavi, J., Miller, D. M., Bagga, I., Schempf, A. M., Hsu, Y.-M., Woods, B. D., et al. (2021) · The Journals of Gerontology Series A · doi:10.1093/gerona/glab145 · Cited by 34
Ohta, H., Konishi, M., Kobayashi, Y., Kashio, A., Mochiyama, T., Matsumura, S., Inoue, K., Fushiki, T., Nakao, K., Kimura, I., et al. (2015) · Scientific Reports · doi:10.1038/srep10049 · Cited by 37
Role of fibroblast growth factors in elicitation of cell responses
Laestander, C., & Engström, W. (2013) · Cell Proliferation · doi:10.1111/cpr.12084 · Cited by 35
ANGPTL6 expression is coupled with mitochondrial OXPHOS function to regulate adipose FGF21
Kang, S., Yi, H., Choi, M. J., Ryu, M. J., Jung, S.-B., Chung, H. K., Chang, J. Y., Kim, Y. K., Lee, S. E., Kim, H. W., et al. (2017) · Journal of Endocrinology · doi:10.1530/joe-16-0549 · Cited by 36
Dietary protein dilution limits dyslipidemia in obesity through FGF21-driven fatty acid clearance
Maida, A., Zota, A., Vegiopoulos, A., Appak‐Baskoy, S., Augustin, H. G., Heikenwälder, M. F., Herzig, S., & Rose, A. J. (2018) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2018.03.027 · Cited by 34
Metabolic actions of FGF21: molecular mechanisms and therapeutic implications
Ge, X., Wang, Y., Lam, K. S., & Xu, A. (2012) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2012.06.011 · Cited by 35
Glucagon receptor signaling regulates weight loss via central KLB receptor complexes
Nason, S. R., Antipenko, J., Presedo, N., Cunningham, S. E., Pierre, T. H., Kim, T., Paul, J. R., Holleman, C., Young, M. E., Gamble, K. L., et al. (2021) · JCI Insight · doi:10.1172/jci.insight.141323 · Cited by 34
Miao, X., Alidadipour, A., Saed, V., Sayyadi, F., Jadidi, Y., Davoudi, M., Amraee, F., Jadidi, N., & Afrisham, R. (2024) · Acta Diabetologica · doi:10.1007/s00592-024-02335-9 · Cited by 37
Cole, A. J., Teigen, L. M., Jahansouz, C., Earthman, C. P., & Sibley, S. D. (2015) · Current Obesity Reports · doi:10.1007/s13679-015-0171-x · Cited by 34
Wang, J., Zhu, X., She, G., Kong, Y., Guo, Y., Wang, Z., Liu, G., & Zhao, B. (2018) · BMC Veterinary Research · doi:10.1186/s12917-018-1560-7 · Cited by 34
Sawada, Y., Izumida, Y., Takeuchi, Y., Aita, Y., Wada, N., Li, E., Murayama, Y., Piao, X., Shikama, A., Masuda, Y., et al. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.09.081 · Cited by 31
Archer, A., Venteclef, N., Mode, A., Pedrelli, M., Gabbi, C., Clément, K., Parini, P., Gustafsson, J.-Α., & Korach-André, M. (2012) · Molecular Endocrinology · doi:10.1210/me.2012-1151 · Cited by 33
Dai, Q., Fan, X., Meng, X., Sun, S., Su, Y., Ling, X., Chen, X., Wang, K., Dai, X., Zhang, C., et al. (2021) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.16369 · Cited by 33
A solid-phase PEGylation strategy for protein therapeutics using a potent FGF21 analog
Song, L., Zhu, Y., Wang, H., Belov, A. A., Niu, J., Shi, L., Xie, Y., Ye, C., Li, X., & Huang, Z. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.03.023 · Cited by 32
Liu, Y., Wang, C., Wang, Y., Ma, Z., Xiao, J., McClain, C. J., Li, X., & Feng, W. (2012) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2012.08.003 · Cited by 32
Kobayashi, M., Uta, S., Otsubo, M., Deguchi, Y., Tagawa, R., Mizunoe, Y., Nakagawa, Y., Shimano, H., & Higami, Y. (2020) · Nutrients · doi:10.3390/nu12072054 · Cited by 32
Role of fibroblast growth factors in organ regeneration and repair
Agha, E. E., Kosanovic, D., SCHERMULY, R. T., & Bellusci, S. (2015) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2015.10.009 · Cited by 33
Fibroblast growth factor 21 enhances cholesterol efflux in THP-1 macrophage-derived foam cells
Shang, W., Yu, X., Wang, H., CHEN, T., Fang, Y., Yang, X., Zhou, P., Nie, F., ZHOU, Q., & Zhou, J.-Z. (2014) · Molecular Medicine Reports · doi:10.3892/mmr.2014.2731 · Cited by 32
Hirai, T., Mitani, Y., Kurumisawa, K., Nomura, K., Wang, W., Nakashima, K., & Inoue, M. (2019) · Biochemical Pharmacology · doi:10.1016/j.bcp.2019.04.017 · Cited by 31
Adipocyte transdifferentiation and its molecular targets
Rajan, S., Gupta, A., Beg, M., Shankar, K., Srivastava, A., Varshney, S., Kumar, D., & Gaikwad, A. N. (2014) · Differentiation · doi:10.1016/j.diff.2014.07.002 · Cited by 29
Murphy, M., Samms, R. J., Warner, A., Bolborea, M., Barrett, P., Fowler, M. J., Brameld, J. M., Tsintzas, K., Kharitonenkov, A., Adams, A. C., et al. (2012) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2012.02383.x · Cited by 29
Chalvon‐Demersay, T., Even, P. C., Chaumontet, C., Piedcoq, J., Viollet, B., Gaudichon, C., Tomé, D., Foretz, M., & Azzout‐Marniche, D. (2017) · Journal of Nutrition · doi:10.3945/jn.117.250803 · Cited by 29
Ling, A. V., Gearing, M. E., Semova, I., Shin, D., Clements, R. L., Lai, Z. W., & Biddinger, S. B. (2017) · Endocrinology · doi:10.1210/en.2017-00870 · Cited by 30
Yan, B., Mei, Z., Tang, Y., Song, H., Wu, H., Jing, Q., Zhang, X., Yan, C., & Han, Y. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-05842-9 · Cited by 29
Nelson, B. T., Ding, X., Bonéy-Montoya, J., Gerard, R. D., Kliewer, S. A., & Andrews, M. T. (2013) · PLoS ONE · doi:10.1371/journal.pone.0053574 · Cited by 28
Lockie, S. H., Stark, R., Méquinion, M., Ch’ng, S. S., Kong, D., Spanswick, D. C., Lawrence, A. J., & Andrews, Z. B. (2018) · Endocrinology · doi:10.1210/en.2018-00536 · Cited by 27
Conjugated linoleic acid induces hepatic expression of fibroblast growth factor 21 through PPAR-α
Yu, J., Yu, B., Jiang, H., & Chen, D. (2011) · British Journal Of Nutrition · doi:10.1017/s0007114511003205 · Cited by 28
Adapting to the cold: A role for endogenous fibroblast growth factor 21 in thermoregulation?
Klein Hazebroek, M., & Keipert, S. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00389 · Cited by 27
ter Horst, K. W., Gilijamse, P. W., Demirkıran, A., van Wagensveld, B. A., Ackermans, M. T., Verheij, J., Romijn, J. A., Nieuwdorp, M., Maratos–Flier, E., Herman, M. A., et al. (2017) · Molecular Metabolism · doi:10.1016/j.molmet.2017.08.014 · Cited by 28
Metadata
- Authors
- Hotta, Y., Nakamura, H., Konishi, M., Murata, Y., Takagi, H., Matsumura, S., Inoue, K., Fushiki, T., & Itoh, N.
- Affiliations
- Kyoto University (JP)
- Corresponding author
- Konishi, Morichika
- Venue
- Endocrinology
- Publisher
- The Endocrine Society
- Published
- 2009-07-09
- Volume
- 150
- Issue
- 10
- Pages
- 4625-4633
- ISSN
- 0013-7227 (ISSN-L)
- 1945-7170
- OpenAlex
- W2042911346
- Cited by
- 352
- References
- 25
- Citations by year
- 2026: 13 · 2025: 14 · 2024: 20 · 2023: 14 · 2022: 19 · 2021: 13 · 2020: 18 · 2019: 25 · 2018: 27 · 2017: 28 · 2016: 27 · 2015: 30 · 2014: 24 · 2013: 23 · 2012: 30
- FWCI
- 7.78
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fibroblast Growth Factor Research
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
- Keywords
- FGF21, lipolysis, white adipose tissue, ketogenesis, triglyceride clearance, liver, fasting, free fatty acids, adipocyte hypertrophy, FGF21 knockout mice, energy metabolism, ketogenic diet
- MeSH terms
- Animals, Fasting, Fibroblast Growth Factors, Glycogen, Ketone Bodies, Lipolysis, Liver, Male, Mice, Inbred C57BL, Phenotype, Triglycerides, Gene Expression, Adipocytes, Mice, Knockout, Mice, Adipose Tissue, White, Gene Knockout Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review